# A Study in Leukemia Patients With Karonudib

> **NCT04077307** · PHASE1 · RECRUITING · sponsor: **Thomas Helleday Foundation** · enrollment: 9 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** Karonudib

## Key facts

- **NCT ID:** NCT04077307
- **Lead sponsor:** Thomas Helleday Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-03
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04077307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04077307, "A Study in Leukemia Patients With Karonudib". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04077307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*